1994 …2023
If you made any changes in Pure these will be visible here soon.

Personal profile


Professor John Zalcberg was the Director, Division of Cancer Medicine, at the Peter MacCallum Cancer Centre in Melbourne, Australia for 17 years prior to recently taking up the position of Professor of Cancer Research in the School of Public Health and Preventive Medicine at Monash University.
After earning a Bachelor of Medicine and Bachelor of Surgery from the University of Melbourne and a PhD in cancer immunology, he served as Director of Medical Oncology at the Heidelberg Repatriation Hospital and as Director of Cancer Services at the Austin and Repatriation Medical Centre.
A founder of the Lorne Cancer Conference and the Australasian Gastrointestinal Trials Group (AGITG), he is immediate past Chair of the Board of AGITG after serving in this role for over 15 years and a past Board Member of Cancer Trials Australia. He is the current Co-Chair of the Cancer Drugs Alliance and Interim Chair of the Australian Clinical Trials Alliance.
A past Board Member of the NSW Cancer Institute, past President of the Clinical Oncological Society of Australia, and a past Member of the Consultative Council of the Victorian Cancer Agency, he has received a Medal of the Order of Australia Award (OAM) and the 2011 Cancer Achievement Award from the Medical Oncology Group of Australia.
Professor Zalcberg's clinical research interests include gastrointestinal cancer and health care outcomes. He has published more than 230 articles in peer-reviewed journals. He was a Principal Investigator for the EORTC advanced GIST trial in Australia and continues an active involvement in trials in this disease as well as other GI cancers. He continues an active clinical practice in GI cancer.

Current Appointments:

2014 - Professor of Cancer Research
2012 - Interim Chair, Australian Clinical Trials Alliance
2013 - NED, Board of Australian Red Cross Blood Service
2013 - Co-Chair, Cancer Drugs Alliance
2009 - Member, External Advisory Board of South London Integrated Cancer Centre

Board Positions:

1993 - 2014 Australasian Gastrointestinal Trials Group
1995 - 2008 Progen Pharmaceuticals
2003 - 2014 Cancer Trials Australia
2003 - 2005 NSW Cancer Institute
2012 - Cancer Drugs Alliance
2013 - Australian Red Cross Blood Service
2013 - Australian Clinical Trials Alliance

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2023

Research Output 1994 2018

Exploring patient-reported outcomes following percutaneous coronary intervention: A qualitative study

Ayton, D. R., Barker, A. L., Peeters, G. M. E. E., Berkovic, D. E., Lefkovits, J., Brennan, A., Evans, S., Zalcberg, J., Reid, C., Stoelwinder, J. J. & McNeil, J., Apr 2018, In : Health Expectations. 21, 2, p. 457-465

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Potential solutions to improve the governance of multicentre health services research

Evans, S. M., Zalcberg, J. R. & Scarborough, R., 2018, In : Medical Journal of Australia. 209, 4, p. 187-187.e1 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Telehealth models could be extended to conducting clinical trials-a teletrial approach

Sabesan, S. & Zalcberg, J., Mar 2018, In : European Journal of Cancer Care. 27, 2, e12587.

Research output: Contribution to journalComment / DebateOtherpeer-review